Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Amphastar Pharmaceuticals, Inc. (AMPH) had Earnings per Share (EPS) (Basic) of $0.38 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$191.84M |
|
$17.35M |
|
$93.19M |
|
$98.65M |
|
$166.52M |
|
$25.32M |
|
$-3.81M |
|
$21.51M |
|
$21.51M |
|
$17.35M |
|
$17.35M |
|
$17.35M |
|
$17.35M |
|
$25.32M |
|
$40.33M |
|
46.47M |
|
47.68M |
|
|
Earnings per Share (EPS) (Basic) |
$0.38 |
$0.37 |
|
| Balance Sheet Financials | |
$639.47M |
|
$308.69M |
|
$1.03B |
|
$1.67B |
|
$205.23M |
|
$608.58M |
|
$684.25M |
|
$889.48M |
|
$776.75M |
|
$204.51M |
|
$776.75M |
|
46.35M |
|
| Cash Flow Statement Financials | |
$123.25M |
|
$-9.76M |
|
$-49.05M |
|
$151.84M |
|
$216.50M |
|
$64.66M |
|
$21.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.12 |
|
-- |
|
-- |
|
0.44 |
|
0.78 |
|
51.42% |
|
13.20% |
|
13.20% |
|
-- |
|
11.21% |
|
9.04% |
|
$96.64M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.50 |
|
1.29 |
|
69.84 |
|
2.23% |
|
8.48% |
|
1.04% |
|
1.25% |
|
$16.76 |
|
$2.03 |
|
$2.59 |
|